ArticleInternational journal of oncology2021

CXCR4 blockade sensitizes osteosarcoma to doxorubicin by inducing autophagic cell death via PI3K‑Akt‑mTOR pathway inhibition.

Yu-Xin Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.